Variant report
Variant | esv3331288 |
---|---|
Chromosome Location | chr8:64035448-64037696 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186416967 | chr8:64037021-64037022 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191221253 | chr8:64037037-64037038 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540822671 | chr8:64037048-64037049 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562379947 | chr8:64037116-64037117 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529566437 | chr8:64037119-64037120 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182590076 | chr8:64037147-64037148 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370333429 | chr8:64037170-64037171 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564912674 | chr8:64037174-64037175 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562471084 | chr8:64037184-64037185 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532775884 | chr8:64037185-64037186 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540940931 | chr8:64037186-64037187 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551499470 | chr8:64037187-64037188 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371784108 | chr8:64037229-64037230 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566433819 | chr8:64037249-64037250 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371919624 | chr8:64037263-64037264 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs60028259 | chr8:64037274-64037275 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs529419471 | chr8:64037301-64037302 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12544951 | chr8:64037304-64037305 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs187718620 | chr8:64037323-64037324 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191247086 | chr8:64037326-64037327 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556166399 | chr8:64037333-64037334 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575620100 | chr8:64037343-64037344 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559582408 | chr8:64037344-64037345 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528486459 | chr8:64037353-64037354 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34802823 | chr8:64037354-64037355 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71255379 | chr8:64037364-64037365 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111755201 | chr8:64037369-64037370 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs573219265 | chr8:64037405-64037406 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182453850 | chr8:64037407-64037408 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562238863 | chr8:64037414-64037415 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147327589 | chr8:64037444-64037445 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544956080 | chr8:64037484-64037485 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563020190 | chr8:64037493-64037494 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187487144 | chr8:64037548-64037549 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72659879 | chr8:64037557-64037558 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs35457639 | chr8:64037564-64037565 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs192051830 | chr8:64037573-64037574 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs67836168 | chr8:64037584-64037585 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs567154933 | chr8:64037589-64037590 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73254933 | chr8:64037600-64037601 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs550093200 | chr8:64037610-64037611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571444104 | chr8:64037628-64037629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374741676 | chr8:64037652-64037653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550752942 | chr8:64037653-64037654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539833066 | chr8:64037661-64037662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557823775 | chr8:64037690-64037691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:64037000-64037400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr8:64037000-64037600 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
3 | chr8:64037000-64037800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |